Elsevier integrates JAMA Network content into its ClinicalKey AI platform, strengthening its medical analytics capabilities and supporting long-term growth for parent company RELX.
RELX's subsidiary, Elsevier, has secured a strategic content agreement with the JAMA Network to integrate its full-text content into the ClinicalKey AI platform. This partnership enhances the clinical decision support tool's data repository, potentially increasing its value proposition for healthcare professionals and driving long-term growth for RELX's scientific, technical, and medical division.
The agreement allows ClinicalKey AI to leverage full-text content and visuals from the JAMA Network to provide more comprehensive and evidence-based answers to users.
Elsevier is a subsidiary of RELX.
Elsevier has finalized a strategic content agreement with the JAMA Network to integrate peer-reviewed medical research into its ClinicalKey AI platform. This partnership aims to enhance the accuracy and depth of AI-driven clinical decision support tools, bolstering RELX's position in the medical information technology sector.
The agreement strengthens the data foundation of RELX's ClinicalKey AI platform, potentially increasing its utility and market competitiveness in the healthcare analytics space.